Records containing: Influenza
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2016-07-27Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections
-
CLINICAL_TRIALS study record update · 2016-07-27An Open-label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir in the Treatment of Infants Less Than One Year of Age With Influenza Infection
-
CLINICAL_TRIALS study record update · 2016-07-19An Open-Label, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of CSL's Influenza Vaccine in a Paediatric Population (= or >6 Months to < 9 Years of Age).
-
CLINICAL_TRIALS study record update · 2016-07-19Phase Ia Study of a Pandemic Influenza Vaccine
-
CLINICAL_TRIALS study record update · 2016-07-19A Phase II, Double-Blind, Randomised, Controlled, Multi-Centre Study to Evaluate the Immunogenicity, Safety and Tolerability of Three Formulations of CSL412 in Adults (≥ 18 to ≤ 45 Years) and Older Adults (≥ 60 Years)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2016-07-19Phase II Study of a Pandemic Influenza Vaccine in Elderly Participants
-
CLINICAL_TRIALS study record update · 2016-07-19A Double-Blind, Randomised, Multi-Centre Study to Evaluate the Safety, Tolerability, Immunogenicity and Lot to Lot Consistency of Two Formulations of CSL Limited's Inactivated Prototype Pandemic Influenza Vaccine in a Healthy Adult Population (≤18 Years to ≥64 Years of Age).
-
CLINICAL_TRIALS study record update · 2016-07-19Phase II Study of a Pandemic Influenza Vaccine in Children
-
CLINICAL_TRIALS study record update · 2016-07-19Influenza Resistance Information Study (IRIS)
-
CLINICAL_TRIALS study record update · 2016-07-14Randomized Trial of High Dose Influenza Vaccine in Long Term Care Setting
-
CLINICAL_TRIALS study record update · 2016-07-12Project IMPACT Immunizations (IMProving America's Communities Together)
-
CLINICAL_TRIALS study record update · 2016-06-30Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal Influenza Vaccine
-
CLINICAL_TRIALS study record update · 2016-06-30Prospective Cohort Study to Evaluate Safety and Immunogenicity of Butantan Seasonal
-
CLINICAL_TRIALS study record update · 2016-06-20An Observer-blind Study to Evaluate the Safety and Immunogenicity of GSK Biologicals' Influenza Vaccine(s) GSK3277510A and GSK3277509A Administered in Adults 18 to 60 Years of Age
-
CLINICAL_TRIALS study record update · 2016-06-20Safety and Immunogenicity Study of GSK Biologicals' Quadrivalent Influenza Candidate Vaccine (GSK23211381A) Manufactured With a New Process in Adults and Children
-
CLINICAL_TRIALS study record update · 2016-06-09Double Blind Randomized Placebo-controlled Multicenter Study to Evaluate Clinical Efficacy and Safety of Ingavirin®, Capsules 30 mg, in 3-6 Years Old Patients With Influenza and Other Acute Respiratory Viral Infections in the Course of Standard Therapy
-
CLINICAL_TRIALS study record update · 2016-05-26A Pilot Study to Assess the Acceptability, Tolerability, and Feasibility of Home Intranasal Administration of FluMist® by a Trained Primary Caregiver to Healthy Family Members 2 Through 17 Years of Age
-
CLINICAL_TRIALS study record update · 2016-05-09Influenza A 2009 H1N1 Human Challenge Study in Healthy Adult Volunteers
-
CLINICAL_TRIALS study record update · 2016-05-09A Phase III, Stratified, Randomized, Controlled, Observer-Blind, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of Two Doses of aH5N1when Administered to Adult and Elderly Subjects With and Without Immunosuppressive Conditions
-
CLINICAL_TRIALS study record update · 2016-05-09A Phase Ib, Multi-Center, Randomized, Observer-Blind, Proof of Concept, Dose- and Formulation-Ranging Study to Evaluate Safety, Tolerability, and Immunogenicity of One Dose of Trivalent Inactivated Influenza Vaccine in Different Presentations (Intramuscular and Intradermal Delivery), Dosages (Regular or Higher A/H3N2 Content) and Doses of Adjuvant Administered to Healthy Elderly Aged ≥ 65 Years
-
CLINICAL_TRIALS study record update · 2016-04-21An Open Label Dose-Ranging Influenza Challenge Study in Healthy Volunteers
-
CLINICAL_TRIALS study record update · 2016-04-19Avian/Pandemic Influenza Registry
-
CLINICAL_TRIALS study record update · 2016-04-14Novel Influenza A (H1N1) Surveillance Registry
-
CLINICAL_TRIALS study record update · 2016-04-12Immunogenicity and Safety Study of GSK Biologicals' Quadrivalent Influenza Vaccine (GSK2282512A) Compared to Fluzone® Quadrivalent in Children 6 to 35 Months of Age
-
CLINICAL_TRIALS study record update · 2016-04-05A Phase 2a Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Antiviral Activity of a Single Intravenous Dose of VIS410 in Healthy Subjects After a Viral Inoculation With Influenza A (H1N1)